General Information of Drug (ID: DMBT2ZW)

Drug Name
cmp5 Drug Info
Synonyms ChemBridge ID 9033823
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
6462334
TTD Drug ID
DMBT2ZW

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Clinical Trial Drug(s)
Investigative Drug(s)
Drug Name Drug ID Indication ICD 11 Highest Status REF
GSK3326595 DMJRD7A Breast cancer 2C60-2C65 Phase 2 [2]
AMG 193 DMU9K8N Aggressive cancer 2A00-2F9Z Phase 2 [3]
PRT811 DMW3MCX Glioma 2A00.0 Phase 1 [4]
PRT543 DMHNZ3U Hematologic tumour 2B33.Y Phase 1 [5]
JNJ-64619178 DMDBW2N Myelodysplastic syndrome 2A37 Phase 1 [6]
PF-06939999 DM7BOFR Solid tumour/cancer 2A00-2F9Z Phase 1 [7]
DS-437 DME3WBQ Discovery agent N.A. Investigative [8]
EPZ015666 DM3INX7 Discovery agent N.A. Investigative [9]
⏷ Show the Full List of 8 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Protein arginine methyltransferase 5 (PRMT5) TTR1D7X ANM5_HUMAN Inhibitor [1]

References

1 Selective inhibition of protein arginine methyltransferase 5 blocks initiation and maintenance of B-cell transformation. Blood. 2015 Apr 16;125(16):2530-43.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 AMG 193 Effective in Multiple Tumor Types. Cancer Discov. 2023 Dec 12;13(12):2492.
4 Clinical pipeline report, company report or official report of Prelude Therapeutics.
5 Clinical pipeline report, company report or official report of Prelude Therapeutics.
6 A patent review of arginine methyltransferase inhibitors (2010-2018). Expert Opin Ther Pat. 2019 Feb;29(2):97-114.
7 National Cancer Institute Drug Dictionary (drug name PF-06939999).
8 Discovery of a Dual PRMT5-PRMT7 Inhibitor. ACS Med Chem Lett. 2015 Mar 2;6(4):408-12.
9 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 1256).